Skip to main content
. Author manuscript; available in PMC: 2019 May 17.
Published in final edited form as: Med Care. 2010 Jan;48(1):4–9. doi: 10.1097/MLR.0b013e3181bd4c10

TABLE 2.

Likelihood of Switching Among Established Users of Bipolar Therapy*

Adjusted Odds Ratios
Maine (n = 5336) New Hampshire (n = 1376) Risk Ratios (ME Versus NH)
Phase-in
Versus Prepolicy
Post
Versus Prepolicy
Phase-in
Versus Prepolicy
Post
Versus Prepolicy
Phase-in
Versus Prepolicy
Post
Versus Prepolicy
All established users 1.19 (1.04, 135) 1.13 (1.00, 1.29) 1.15 (0.88, 1.51) 1.27 (0.96, 1.67) 1.03 (0.76, 139) 0.90 (0.66, 1.22)
Using preferred agents prior to switch 1.19 (0.90, 1.57) 0.82 (0.63, 1.06) 0.92 (0.56, 1.51) 1.04 (0.64, 1.69) 1.29 (0.73, 2.28) 0.78 (0.45, 1.35)
Using nonpreferred agents prior to switch 1.06 (0.90, 1.25) 1.12 (0.95, 1.31) 1.16 (0.81, 1.68) 1.31 (0.91, 1.89) 0.91 (0.61, 1.36) 0.85 (0.57, 1.26)
*

Generalized Estimating Equations models control for age, gender, Medicare/Medicaid dual enrollment status, number of unique medications, and inpatient hospitalizations during the past 6 months.

Prepolicy, July 2002 to April 2003; phase-in period, May 2003 to July 2003; policy, August 2003 to February 2004.

P [H11021] 0.05.

HHS Vulnerability Disclosure